Format

Send to

Choose Destination
Oncogene. 2007 Feb 26;26(9):1338-45.

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer.

Author information

1
Molecular Oncology Group and Departments of Biochemistry and Medicine, McGill University, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada.

Abstract

The phosphatidyl inositol 3-kinase (PI3K)/Akt pathway is activated downstream of a variety of extracellular signals and activation of this signaling pathway impacts a number of cellular processes including cell growth, proliferation and survival. The alteration of components of this pathway, through either activation of oncogenes or inactivation of tumor suppressors, disrupts a signaling equilibrium and can thus lead to cellular transformation. The frequent dysregulation of the PI3K/Akt pathway in human cancer has made components of this pathway attractive for therapeutic targeting; however, a more comprehensive understanding of the signaling intricacies is necessary to develop pharmacological agents to target not only specific molecules, but also specific functions. Here, we review a series of experiments examining the contribution of molecules of this signaling network including PI3K, phosphatase and tensin homolog deleted on chromosome 10, integrin-linked kinase and Akt and address the significance to human breast cancer.

PMID:
17322919
DOI:
10.1038/sj.onc.1210202
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center